Status:
COMPLETED
Xience V at Wake Forest University Baptist Medical Center (WFUBMC)
Lead Sponsor:
Wake Forest University
Collaborating Sponsors:
Abbott
Conditions:
Percutaneous Coronary Intervention
Stents
Eligibility:
All Genders
18+ years
Brief Summary
The effectiveness, safety, and deliverability of second generation drug eluting stents (DES), including Xience V, will need to be examined in real world patients to provide the same level of evidence ...
Eligibility Criteria
Inclusion
- percutaneous coronary intervention with stenting
Exclusion
- none
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00937573
Start Date
July 1 2009
End Date
August 1 2013
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States, 27517